Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 5/2016

01-05-2016 | Breast Oncology

Risk of Local Recurrence of Benign and Borderline Phyllodes Tumors: A Danish Population-Based Retrospective Study

Authors: Kaveh Borhani-Khomani, MS, Maj-Lis Møller Talman, MD, Niels Kroman, MD, DMSc, Tove Filtenborg Tvedskov, MD, PhD

Published in: Annals of Surgical Oncology | Issue 5/2016

Login to get access

Abstract

Purpose

To determine the recurrence rate of benign and borderline phyllodes tumors (PTs) of the breast, the association between the size of resection margin and risk of recurrence and the risk of progression of histological grading at recurrence.

Methods

Nationwide retrospective study on Danish women aged 18 years or older, operated from 1999 to 2014, with resected benign or borderline PTs. Information on age, size of primary tumor and recurrence, histological grade, surgical treatment, margin size, and local recurrence were collected from the national Danish Pathology Register.

Results

A total of 479 cases were identified; 354 benign (74 %), 89 borderline (19 %), 6 uncertain histological grading (1.2 %), and 30 possibly PT (6 %). The mean age at presentation was 45.6 years (range 18–85), the mean tumor size was 3.5 cm (range 0.5–21), and the mean follow-up time was 98 months (range 1.1–192). We identified 30 local recurrences, i.e., a recurrence rate of 6.3 %. Twenty-three recurrences had similar or lower histological grading than the primary tumor, one primary benign PT recurred as a tumor with unclear diagnosis, and one primary borderline PT recurred as malignant. The number of recurrences was too low, and the information on the size of the closest resection margin was too sparse to estimate an adequate margin size for excision of nonmalignant PTs.

Conclusions

The recurrence rate of PTs was considerably lower than previously stated in literature. No apparent pattern of progression in histological grading was found. The results do not justify wide excision margins of nonmalignant phyllodes tumors of the breast.
Literature
1.
Kim S, Kim JY, Kim do H, Jung WH, Koo JS. Analysis of phyllodes tumor recurrence according to the histologic grade. Breast Cancer Res Treat. 2013;141(3):353–63.CrossRefPubMed
2.
Karim RZ, Gerega SK, Yang YH, Spillane A, Carmalt H, Scolyer RA, Lee CS. Phyllodes tumours of the breast: a clinicopathological analysis of 65 cases from a single institution. Breast. 2009;18(3):165–70.CrossRefPubMed
3.
Lakhani SR, Ellis IO, Schnitt SJ, et al. WHO classification of Tumours of the Breast, 4th edn. IARC Press, Lyon, 2012:143–7.
4.
Tan PH, Jayabaskar T, Chuah KL, et al. Phyllodes tumors of the breast: the role of pathologic parameters. Am J Clin Pathol. 2005;123(4):529–40.CrossRefPubMed
5.
Reinfuss M, Mituś J, Duda K, Stelmach A, Ryś J, Smolak K. The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases. Cancer. 1996;77(5):910–6.CrossRefPubMed
6.
Chen WH, Cheng SP, Tzen CY, Yang TL, Jeng KS, Liu CL, Liu TP. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases. J Surg Oncol. 2005;91(3):185–94.CrossRefPubMed
7.
Taira N, Takabatake D, Aogi K, Ohsumi S, Takashima S, Nishimura R, Teramoto N. Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis predictive factors for local recurrence in patients with a positive surgical margin. Jpn J Clin Oncol. 2007;37(10):730–6.CrossRefPubMed
8.
Barth RJ Jr. Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors. Breast Cancer Res Treat. 1999;57(3):291–5.CrossRefPubMed
9.
10.
McCarthy E, Kavanagh J, O’Donoghue Y, McCormack E, D’Arcy C, O’Keeffe SA. Phyllodes tumours of the breast: radiological presentation, management and follow-up. Br J Radiol. 2014; 87: 20140239.CrossRefPubMedPubMedCentral
11.
Yom CK, Han W, Kim SW, Park SY, Park IA, Noh DY. Reappraisal of conventional risk stratification for local recurrence based on clinical outcomes in 285 resected phyllodes tumors of the breast. Ann Surg Oncol. 2015 doi: 10.​1245/​s10434-015-4395-5.PubMed
12.
Tan EY, Tan PH, Yong WS, Wong HB, Ho GH, Yeo AW, Wong CY. Recurrent phyllodes tumours of the breast: pathological features and clinical implications. ANZ J Surg. 2006;76(6):476–80.CrossRefPubMed
13.
Hajdu SI, Espinosa MH, Robbins GF. Recurrent cystosarcoma phyllodes a clinicopathologic study of 32 cases. Cancer. 1976;38(3):1402–6.CrossRefPubMed
14.
Tan PH, Thike AA, Tan WJ, et al. Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins. J Clin Pathol. 2012;65(1):69–76.CrossRefPubMed
15.
Bjerregaard B, Larsen OB. The Danish Pathology Register. Scand J Public Health. 2011;39(7 Suppl):72–4.CrossRefPubMed
16.
17.
Akcakaya A, Koc B, Erozgen F, et al. Unpredictable behavior of breast phyllodes tumors. Eur Rev Med Pharmacol Sci. 2014;18(18):2655–61.PubMed
18.
Spitaleri G, Toesca A, Botteri E, Bottiglieri L, et al. Breast phyllodes tumor: a review of literature and a single center retrospective series analysis. Crit Rev Oncol Hematol. 2013;88(2):427–36.CrossRefPubMed
19.
Christiansen P, Vejborg I, Kroman N, Holten I, Garne JP, Vedsted P, Moller S, Lynge E. Position paper: breast cancer screening, diagnosis, and treatment in Denmark. Acta Oncol. 2014; 53.4: 433–444.CrossRefPubMed
20.
Nio Y, Iguchi C, Tsuboi K, Maruyama R. Ductal carcinoma in situ arising within a benign phyllodes tumor: a case report with a review of the literature. Oncol Lett. 2011;2(2):223–8.CrossRefPubMedPubMedCentral
21.
Jara-Lazaro AR, Tan PH. Molecular pathogenesis of progression and recurrence in breast phyllodes tumors. Am J Transl Res. 2009;1(1):23–34.PubMedPubMedCentral
22.
Stebbing JF, Nash AG. Diagnosis and management of phyllodes tumour of the breast: experience of 33 cases at a specialist centre. Ann R Coll Surg Engl. 1995;77(3):181–4.PubMedPubMedCentral
23.
24.
Barrio AV, Clark BD, Goldberg JI, et al. Clinicopathologic features and long term outcomes of 293 phyllodes tumors of the breast. Ann Surg Oncol. 2007;14(10):2961–70.CrossRefPubMed
25.
Wei J, Tan YT, Cai YC, et al. Predictive factors for the local recurrence and distant metastasis of phyllodes tumors of the breast: a retrospective analysis of 192 cases at a single center. Chin J Cancer. 2014;33(10):492–500.PubMedPubMedCentral
26.
Lin CC, Chang HW, Lin CY, Chiu CF, Yeh SP. The clinical features and prognosis of phyllodes tumors: a single institution experience in Taiwan. Int J Clin Oncol. 2013;18(4):614–20.CrossRefPubMed
27.
Vilela MH, de Almeida FM, de Paula GM, Ribeiro NB, Cirqueira MB, Silva AL, Moreira MA. Utility of Ki-67, CD10, CD34, p53, CD117, and mast cell content in the differential diagnosis of cellular fibroadenomas and in the classification of phyllodes tumors of the breast. Int J Surg Pathol. 2014;22(6):485–91.CrossRefPubMed
28.
Kucuk U, Bayol U, Pala EE, Cumurcu S. Importance of P53, Ki-67 expression in the differential diagnosis of benign/malignant phyllodes tumors of the breast. Indian J Pathol Microbiol. 2013;56(2):129–34.CrossRefPubMed
29.
Khazai L, Middleton LP, Goktepe N, Liu BT, Sahin AA. Breast pathology second review identifies clinically significant discrepancies in over 10% of patients. J Surg Oncol. 2015;111(2):192–7.CrossRefPubMed
30.
Lawton TJ, Acs G, Argani P, et al. Interobserver variability by pathologists in the distinction between cellular fibroadenomas and phyllodes tumors. Int J Surg Pathol. 2014;22(8):695–8.CrossRefPubMedPubMedCentral
Metadata
Title
Risk of Local Recurrence of Benign and Borderline Phyllodes Tumors: A Danish Population-Based Retrospective Study
Authors
Kaveh Borhani-Khomani, MS
Maj-Lis Møller Talman, MD
Niels Kroman, MD, DMSc
Tove Filtenborg Tvedskov, MD, PhD
Publication date
01-05-2016
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 5/2016
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-015-5041-y

Other articles of this Issue 5/2016

Annals of Surgical Oncology 5/2016 Go to the issue

Gastrointestinal Oncology

The Role of Ki-67 and Pre-cytoreduction Parameters in Selecting Diffuse Malignant Peritoneal Mesothelioma (DMPM) Patients for Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Colorectal Cancer

Angiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer

Colorectal Cancer

Robotic Versus Laparoscopic Total Mesorectal Excision (TME) for Sphincter-Saving Surgery: Is There Any Difference in the Transanal TME Rectal Approach?

Gastrointestinal Oncology

Routine Admission to Intensive Care Unit After Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy: Not Always a Requirement

Breast Oncology

Fertility Preservation for the Young Breast Cancer Patient

Gastrointestinal Oncology

Malignant Peritoneal Mesothelioma: Characterization of the Inflammatory Response in the Tumor Microenvironment